Security readout for executives and security teams
Plain-English summary
CVE-2026-21974 is an information disclosure issue in Oracle Life Sciences Central Designer. An unauthenticated attacker who can reach the application over HTTP may read some accessible data without logging in. The known affected version is 7.0.1.0. Oracle rates it CVSS 5.3, reflecting limited confidentiality impact and no integrity or availability impact.
Executive priority
Treat as a timely remediation item for environments using Central Designer 7.0.1.0, especially if reachable from broad networks. The business risk is unauthorized disclosure of limited application data, not system takeover or outage based on current sources.
Technical view
The vulnerability affects the Platform component of Oracle Life Sciences Central Designer 7.0.1.0. It is categorized as CWE-200 and has CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N. Exploitation requires network access via HTTP, no privileges, and no user interaction. Successful exploitation may disclose a subset of application data.
Likely exposure
Organizations running Oracle Life Sciences Central Designer 7.0.1.0 with HTTP access reachable by untrusted networks face the main exposure. Internet-facing deployments are higher concern than internal-only systems.
Exploitation context
The provided sources do not report active exploitation, and the CVE is not listed as KEV in the supplied data. The vulnerability is described as easily exploitable because it is remote, unauthenticated, low complexity, and requires no user interaction.
Researcher notes
Source evidence is limited to the CVE record and Oracle advisory reference. No exploit details, proof-of-concept, or exploitation-in-the-wild evidence were provided. Validate affected build, network reachability, and Oracle CPU applicability before prioritizing remediation windows.
Mitigation direction
- Review Oracle’s January 2026 Critical Patch Update for this CVE.
- Apply Oracle-provided fixes or upgrade guidance for Central Designer 7.0.1.0.
- Restrict HTTP access to trusted networks where operationally possible.
- Monitor application access logs for unusual unauthenticated data access patterns.
Validation and detection
- Confirm whether Oracle Life Sciences Central Designer is deployed.
- Identify whether version 7.0.1.0 is in use.
- Verify exposure of HTTP interfaces to untrusted networks.
- Check patch status against Oracle’s January 2026 advisory.
- Document compensating controls if vendor remediation is not yet applied.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-200: Information exposure and cloud metadata lookup
Information exposure and SSRF weaknesses can make discovery, cloud metadata, and credential material review relevant. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2026-21974 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 5.3 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N3.91.4Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
5.3MediumVector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Source materials
- CVE List V5 sourceCVE List V5
- Oracle AdvisoryCVE reference · vendor-advisory
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Exposure of Sensitive Information to an Unauthorized Actor
Exposure of Sensitive Information to an Unauthorized Actor represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.